
    
      The secondary objectives of this study are to evaluate changes in the following elements
      before versus after 8 bi-weekly treatments of LIESWT:

      A. EF categorical improvement.

      B. Other validated measures of EF (SEP2 (question 2 of the sexual encounter profile), SEP3
      (question 3 of the sexual encounter profile), GAQ (Global Assessment Question), EHS (Erection
      Hardness Score)), and the remaining domains of the IIEF score (orgasmic function, sexual
      desire, intercourse satisfaction, overall satisfaction), as well as the total IIEF score.

      C. Harms/Safety: To evaluate treatment tolerance and potential adverse events.
    
  